In our data, ESRP1/2 silencing altered the expression of almost one thousand genes, including several interferon-responsive genes such as IFI27 and IFI6, whose expression is associated with reduced OS in BC patients [32,33]. The gene discussed is IFI27; the disease is breast cancer.